Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. House. Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022. H.R. 7630. 117th Cong., 2nd sess., Introduced in House April 28, 2022. https://www.govinfo.gov/app/details/BILLS-117hr7630ih.
Congress, House of Representatives (2022, April 28). Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 (H.R. 7630 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-117hr7630ih.
United States, Congress, House of Representatives. Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-117hr7630ih. 117th Congress, H.R. 7630, Introduced in House 28 Apr. 2022.
H.R.7630 - 117th Congress (2021-2022): Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022, H.R.7630, 117th Cong. (2022), https://www.govinfo.gov/app/details/BILLS-117hr7630ih.